8.88MMarket Cap-0.20P/E (TTM)
2.0400High1.9600Low154.81KVolume1.9880Open1.8900Pre Close308.22KTurnover3.53%Turnover RatioLossP/E (Static)4.46MShares42.922552wk High-4.33P/B8.72MFloat Cap1.830052wk Low--Dividend TTM4.38MShs Float550.0000Historical High--Div YieldTTM4.23%Amplitude1.8300Historical Low1.9910Avg Price1Lot Size
SeaStar Medical Stock Forum
NFA = not financial advice
RTH = regular trading hours
AH = after hours
LTB = left to borrow
CTB = cost to borrow
*I removed $AmpliTech Group (AMPG.US)$ because it just announced direct offering of $2M valued $1.6/shares. Now there are offerings where market defies it and continues to rally. We shall see tomorrow
$Nuburu (BURU.US)$ PR AH 12/11: Resolved compliance issue. Up AH. Low float. CTB...
looks like money
@Seastar Investor Bullish_af.
Benzinga· 5 mins ago
The SCD has been awarded FDA Breakthrough Device Designation (BDD) in three of the five indications included in the chart above, namely adult AKI, hepatorenal syndrome and cardiorenal syndrome with LVAD. The SCD was also awarded BDD for chronic dialysis in November 2024.
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
Wednesday, 11th December at 6:30 am
U.S. total addressable market for five initial indications is $25 to $33 billion
REMINDER: Business Update Conference Call begins at 4:30 p.m. Eastern time today
DENVER , Dec. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ: ICU), a commercial-stage medical device company develo...
📊⚡️📊
No comment yet